113 related articles for article (PubMed ID: 2732444)
1. Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis.
Vinel JP; Caucanas JP; Combis JM; Cales P; Voigt JJ; Pascal JP
J Hepatol; 1989 May; 8(3):302-7. PubMed ID: 2732444
[TBL] [Abstract][Full Text] [Related]
2. The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.
Merkel C; Gatta A; Bolognesi M; Padrini R; Finucci GF; Angeli P; Ruol A
Br J Clin Pharmacol; 1988 Sep; 26(3):273-7. PubMed ID: 3179167
[TBL] [Abstract][Full Text] [Related]
3. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.
Navasa M; Bosch J; Reichen J; Bru C; Mastai R; Zysset T; Silva G; Chesta J; Rodés J
Hepatology; 1988; 8(4):850-4. PubMed ID: 3391511
[TBL] [Abstract][Full Text] [Related]
4. The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis.
Kong CW; Lay CS; Tsai YT; Yeh CL; Lai KH; Lee SD; Lo KJ; Chiang BN
Hepatology; 1986; 6(3):423-6. PubMed ID: 3710430
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis.
Merkel C; Bolognesi M; Angeli P; Finucci GF; Amodio P; Bellon S; Gatta A
Br J Clin Pharmacol; 1990 Aug; 30(2):221-7. PubMed ID: 2206784
[TBL] [Abstract][Full Text] [Related]
6. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
[TBL] [Abstract][Full Text] [Related]
7. Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis.
Vinel JP; Caucanas JP; Calès P; Suduca JM; Voigt JJ; Pascal JP
J Hepatol; 1988 Oct; 7(2):186-92. PubMed ID: 3192922
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects.
Albillos A; Bañares R; Barrios C; Clemente G; Rossi I; Escartin P; Bosch J
Gastroenterology; 1992 Jan; 102(1):248-54. PubMed ID: 1727758
[TBL] [Abstract][Full Text] [Related]
9. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
[TBL] [Abstract][Full Text] [Related]
10. Presinusoidal portal hypertension in non-alcoholic cirrhosis.
Pomier-Layrargues G; Kusielewicz D; Willems B; Villeneuve JP; Marleau D; Côté J; Huet PM
Hepatology; 1985; 5(3):415-8. PubMed ID: 3997071
[TBL] [Abstract][Full Text] [Related]
11. Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
Hadengue A; Moreau R; Cerini R; Koshy A; Lee SS; Lebrec D
Hepatology; 1989 Jan; 9(1):83-7. PubMed ID: 2908872
[TBL] [Abstract][Full Text] [Related]
12. Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis.
Kim MY; Baik SK; Yea CJ; Lee IY; Kim HJ; Park KW; Kim HK; Suk KT; Kim JW; Kim HS; Kwon SO; Cha SH; Kim YJ; Koh SB; Chang SJ
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1241-6. PubMed ID: 19455045
[TBL] [Abstract][Full Text] [Related]
13. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients.
Ottesen LH; Flyvbjerg A; Møller S; Bendtsen F
Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530
[TBL] [Abstract][Full Text] [Related]
14. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
15. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
Lay CS; Tsai YT; Kong CW; Lee FY; Chang TT; Lin HC; Yang CM; Lee SD; Chiang BN; Lo KJ
Clin Pharmacol Ther; 1988 Oct; 44(4):453-7. PubMed ID: 3168396
[TBL] [Abstract][Full Text] [Related]
16. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
García-Pagán JC; Feu F; Luca A; Fernández M; Pizcueta P; Bosch J; Rodés J
J Hepatol; 1994 Jun; 20(6):792-6. PubMed ID: 7930480
[TBL] [Abstract][Full Text] [Related]
17. Portal hemodynamics during nitroglycerin administration in cirrhotic patients.
Garcia-Tsao G; Groszmann RJ
Hepatology; 1987; 7(5):805-9. PubMed ID: 3115881
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosis.
Bendtsen F; Henriksen JH; Becker U; Sørensen TI
J Hepatol; 1987 Oct; 5(2):137-43. PubMed ID: 3693857
[TBL] [Abstract][Full Text] [Related]
19. Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.
Merkel C; Sacerdoti D; Finucci GF; Zuin R; Bazzerla G; Bolognesi M; Gatta A
Br J Clin Pharmacol; 1986 Jun; 21(6):713-9. PubMed ID: 3741719
[TBL] [Abstract][Full Text] [Related]
20. Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis.
Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Chen KY; Chiang BN; Lo KJ
Hepatogastroenterology; 1988 Jun; 35(3):121-4. PubMed ID: 3402902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
